Quick Summary
- Bitcoin advanced approximately 5% to reach $71,418, pushing crypto-related equities higher with Strategy (+8%), Coinbase (+7%), and Riot Platforms (+4%)
- Moderna reached a $950M settlement in its patent dispute concerning COVID-19 vaccine technology, coming in below market concerns
- Ross Stores exceeded Q4 projections and increased guidance, sending shares up as much as 7.5%
- GitLab declined roughly 9% following Q4 results, citing annual revenue guidance that disappointed analysts
- Horizon Technology Finance tumbled 10% as total investment income reached $20.7M versus the $23.9M estimate
Bitcoin staged a significant recovery Wednesday, advancing approximately 5% to settle near $71,418. This upward movement created momentum for crypto-related equities throughout the trading session.
Strategy posted gains of 8%, while Coinbase climbed around 7%, with MARA Holdings matching that 7% increase. Riot Platforms, Robinhood Markets, Galaxy Digital, and Hut 8 each recorded advances ranging from 4% to 5%. Circle Internet Group contributed to the rally with a 6% gain.
The cryptocurrency rebound followed a recent downturn connected to escalating Middle East geopolitical concerns. Market participants appeared to regain appetite for risk-oriented investments as conditions showed signs of stabilization.
Gold mining companies similarly posted gains Wednesday. Newmont advanced 2.8% while Freeport-McMoRan increased 1.9%, benefiting from ongoing Middle East uncertainty that encouraged capital flows toward traditional safe-haven commodities like gold.
Moderna Resolves $950M Patent Dispute
Moderna finalized a $950 million agreement with Arbutus Biopharma and Genevant Sciences, concluding patent litigation related to its COVID-19 and RSV vaccine technologies.
Market participants viewed the settlement amount favorably, given expectations had centered on a substantially higher figure. Moderna’s COVID-19 vaccine program has produced revenue ranging from $45 billion to $50 billion.
The company will make the payment during Q3 while recognizing the expense in Q1 results. Following the settlement, Moderna anticipates finishing the year holding $4.5 billion to $5 billion in cash reserves.
Moderna plans to continue its appeal with the U.S. Federal Circuit. Success in that appeal could eliminate additional payment obligations, though an unfavorable outcome might trigger an extra $1.3 billion payment within a 90-day window.
Ross Stores delivered impressive performance, climbing as high as 7.5% during premarket hours. The discount retailer surpassed Q4 earnings projections while providing forward guidance that exceeded analyst expectations significantly.
For Q1, Ross forecasts comparable sales growth ranging from 7% to 8%, substantially above the analyst consensus of approximately 3.7%. The retailer simultaneously announced a 10% dividend increase.
GitLab and Horizon Decline Following Conservative Forecasts
GitLab shares retreated between 8.5% and 9% even after surpassing Q4 earnings targets. The software company’s full-year revenue outlook of $1.099 billion to $1.118 billion fell short of the $1.13 billion consensus estimate.
CEO Bill Staples acknowledged dissatisfaction with the revenue projection and presented five strategic initiatives designed to accelerate growth momentum.
Horizon Technology Finance declined 10% following its report of total investment income at $20.7 million, falling below the $23.9 million analyst estimate. The company’s net asset value per share also experienced a modest decline during the period.
CrowdStrike inched up 1.1% after exceeding Q4 earnings and revenue projections. Box surged 6.2% following stronger-than-anticipated results and positive guidance for the ongoing quarter.
Broadcom traded 1% higher ahead of its fiscal first-quarter earnings announcement scheduled after market close, with analysts projecting a 51% year-over-year increase in semiconductor revenue.
